Skip to main content

Month: April 2026

ANI Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 8, 2026, at 8:00 a.m. ET

PRINCETON, N.J., April 24, 2026 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that the Company will release its first quarter 2026 financial results on Friday, May 8, 2026, prior to the market open. Nikhil Lalwani, President and Chief Executive Officer, Stephen P. Carey, Senior Vice President, Finance, and Chief Financial Officer, and Chris Mutz, Head of Rare Disease will host a webcast and conference call to discuss the results. To view the webcast, please click here. Links to access the webcast and conference call will also be available on the “Events & Presentations” page of the Company’s website at https://www.anipharmaceuticals.com, under the “Investors” section. A replay of the event will remain accessible for up to one year. About ANIANI Pharmaceuticals, Inc. (Nasdaq:...

Continue reading

W&T Offshore Announces Timing of First Quarter 2026 Earnings Release and Conference Call

HOUSTON, April 24, 2026 (GLOBE NEWSWIRE) — W&T Offshore, Inc. (NYSE: WTI) (the “Company”) today announced the timing of its first quarter 2026 earnings release and conference call. The Company said it will issue its first quarter 2026 earnings release on Thursday, May 7, 2026, after the close of trading on the NYSE and host a conference call to discuss financial and operational results on Friday, May 8, 2026, at 9:00 a.m. Central Time (10:00 a.m. Eastern Time). Interested parties may participate by dialing (844) 739-3797. International parties may dial (412) 317-5713. Participants should request to be joined to the “W&T Offshore, Inc. Conference Call.” This call will also be webcast and available on W&T Offshore’s website at www.wtoffshore.com under “Investors.” An audio replay will be available on the Company’s website...

Continue reading

INVITATION TO DFDS Q1 2026 CONFERENCE CALL

INVESTOR NEWS no. 15 – 24 April 2026 DFDS expects to publish the Q1 2026 report on 5 May 2026 at around 07:30 CET. Karen Boesen, Interim CEO and CFO, will present the report on a live conference call. The presentation will be followed by a Q&A session. Investors, analysts and other interested parties are invited to take part. Q1 conference call Date:        5 May 2026 Time:        10:00 CET Registration:        Register ahead of the call via this link. Access code is mailed after registration. Live-streaming of the conference call is available from this link.Contact Søren Brøndholt Nielsen, IR +45 33 42 33 59About DFDS We operate a transport network in and around Europe with an annual revenue of DKK 30bn and 16,000 full-time employees. We move goods in trailers by ferry, road & rail, and we offer complementary...

Continue reading

INVITATION TO DFDS Q1 2026 CONFERENCE CALL

INVESTOR NEWS no. 15 – 24 April 2026 DFDS expects to publish the Q1 2026 report on 5 May 2026 at around 07:30 CET. Karen Boesen, Interim CEO and CFO, will present the report on a live conference call. The presentation will be followed by a Q&A session. Investors, analysts and other interested parties are invited to take part. Q1 conference call Date:        5 May 2026 Time:        10:00 CET Registration:        Register ahead of the call via this link. Access code is mailed after registration. Live-streaming of the conference call is available from this link.Contact Søren Brøndholt Nielsen, IR +45 33 42 33 59About DFDS We operate a transport network in and around Europe with an annual revenue of DKK 30bn and 16,000 full-time employees. We move goods in trailers by ferry, road & rail, and we offer complementary...

Continue reading

KE Holdings Inc. to Hold Annual General Meeting on June 12, 2026

BEIJING, April 24, 2026 (GLOBE NEWSWIRE) — KE Holdings Inc. (“Beike” or the “Company”) (NYSE: BEKE and HKEX: 2423), a leading integrated online and offline platform for housing transactions and services, today announced that it will hold an annual general meeting of the Company’s shareholders (the “AGM”) at 3:00 p.m. Beijing time on Friday, June 12, 2026 at Oriental Electronic Technology Building, No. 2 Chuangye Road, Haidian District, Beijing, PRC, for the purposes of considering and, if thought fit, passing each of the Proposed Resolutions as defined and set forth in the notice of the AGM (the “AGM Notice”). A circular of the Company dated April 24, 2026 in relation to the AGM, the AGM Notice and the form of proxy for the AGM are available on the Company’s website at https://investors.ke.com/. The board of directors of the Company...

Continue reading

Johnson Outdoors to Release Fiscal 2026 Second Quarter Results on May 8, 2026

RACINE, Wis., April 24, 2026 (GLOBE NEWSWIRE) — JOHNSON OUTDOORS INC. (Nasdaq: JOUT), a leading global innovator of outdoor recreation equipment and technology, will release financial results for the Fiscal 2026 second quarter on Friday, May 8, 2026, before market open that day. The Company will host a conference call and audio webcast shortly afterwards at 11:00 a.m. Eastern Time to discuss the financial results and provide a Company update. A live listen-only webcast of the conference call may be accessed at Johnson Outdoors’ home page. A replay will be available on the Investor section home page on the Johnson Outdoors’ website – www.johnsonoutdoors.com – for 30 days. ABOUT JOHNSON OUTDOORS INC. JOHNSON OUTDOORS is a leading global innovator of outdoor recreation equipment and technologies that inspire more...

Continue reading

Nano Labs (NA) and ALT5 Sigma Corporation (ALTS) Announce Memorandum of Understanding to Jointly Explore Establishing North America AI data centers, Agent Cloud and AI Infrastructure

HONG KONG, April 24, 2026 (GLOBE NEWSWIRE) — Nano Labs Ltd (Nasdaq: NA) (“we,” the “Company” or “Nano Labs”), a leading Web 3.0 infrastructure and product solution provider, and crypto treasury company, today announced the execution of a structured, non-binding Memorandum of Understanding (the “MOU”) with ALT5 Sigma Corporation (Nasdaq: ALTS) (“ALT5”, collectively with Nano Labs, the “Parties”), to evaluate collaboration across AI data centers, Agent Cloud, and AI-native payments, supported by defined workstreams and joint leadership. ALT5, which is in the process of changing its name to AI Financial Corporation and its Nasdaq ticker symbol to AIFC (“AiFi”), is an AI-powered fintech company operating institutional-grade global payments, trading, and settlement infrastructure. The MOU establishes a defined evaluation process under...

Continue reading

Correction: Final terms for bonds to be listed 24th March 2026

To Nasdaq Copenhagen A/S                        23 March 2026                                        Announcement no. 26/2026Correction: The Initial Coupon was incorrectly stated as 1% in the English version of the Final Terms on ISIN DK0009419137. This has been corrected in the attached document to the correct rate of 0%.Final terms for bonds to be listed 24th March 2026 On 24th March 2026, Jyske Realkredit A/S will be listing 4 new Covered Bonds (SDO) and 1 Mortgage Bond (RO). Final terms for the bonds are attached to this announcement. The full prospectus for the Bonds consists of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds...

Continue reading

Press Release: Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapses

Sanofi’s Cenrifki (tolebrutinib) recommended for EU approval by the CHMP to treat secondary progressive multiple sclerosis without relapsesRecommendation based on the HERCULES phase 3 study which demonstrated that brain-penetrant Cenrifki (tolebrutinib) significantly delayed the onset of disability progression in non-relapsing SPMSParis, April 24, 2026. The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Cenrifki (tolebrutinib) in the EU for the treatment of secondary progressive multiple sclerosis (SPMS) without relapses in the last two years. A final decision is expected in the coming months. SPMS is a debilitating stage of multiple sclerosis where patients experience continuous accumulation of disability, including fatigue, cognitive impairment,...

Continue reading

GRAVITY ANNOUNCES FILING OF ANNUAL REPORT ON FORM 20-F FOR FISCAL YEAR 2025

Seoul, Korea, April 24, 2026 (GLOBE NEWSWIRE) — GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or the “Company”) today announced that the Company filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission on April 24, 2026. The annual report can be accessed on the Company’s investor relations Web site at https://www.gravity.co.kr/en/ir/notice The shareholders and ADS holders of Gravity may receive a hard copy of the annual report, which contains its audited consolidated financial statements, free of charge upon request. Requests should be directed to IR Unit, Gravity Co., Ltd., 15F, 396 World Cup buk-ro, Mapo-gu, Seoul 03925, South Korea. In the annual report on Form 20-F, the consolidated revenue is KRW 560,548 million, the operating profit is KRW 77,396 million,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.